SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,833 | +36.8% | 213,814 | +83.7% | 0.00% | – |
| Q2 2023 | $292,201 | +630.5% | 116,415 | +403.9% | 0.00% | – |
| Q1 2023 | $40,000 | +68865.5% | 23,104 | +70.1% | 0.00% | – |
| Q4 2022 | $58 | -99.6% | 13,582 | +9.6% | 0.00% | – |
| Q3 2022 | $15,000 | +150.0% | 12,392 | +141.3% | 0.00% | – |
| Q2 2022 | $6,000 | -89.7% | 5,135 | -78.6% | 0.00% | – |
| Q1 2022 | $58,000 | -35.6% | 23,984 | -28.4% | 0.00% | – |
| Q4 2021 | $90,000 | +5.9% | 33,487 | +97.6% | 0.00% | – |
| Q3 2021 | $85,000 | -33.6% | 16,943 | -1.2% | 0.00% | – |
| Q2 2021 | $128,000 | -9.9% | 17,155 | -29.2% | 0.00% | – |
| Q1 2021 | $142,000 | -93.9% | 24,222 | -95.1% | 0.00% | – |
| Q4 2020 | $2,321,000 | -57.6% | 493,965 | -68.4% | 0.00% | -100.0% |
| Q3 2020 | $5,478,000 | – | 1,565,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |